If they meet guidance they'll be in the cheapest decile based on EV / EBITDA at approximately 6. Not sure about company specifics but over the long term (many companies & many years) it's proven to be an outperforming metric.
OCC Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil